Anna Maria Gori
Overview
    Explore the profile of Anna Maria Gori including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              152
            
            
              Citations
              2049
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Bevilacqua S, Stefano P, Ranfagni V, Ammannati B, Codecasa R, Gori A, et al.
  
  
    Int Med Case Rep J
    . 2025 Feb;
          18:265-271.
    
    PMID: 39990606
  
  
          Introduction: Heparin-induced thrombocytopenia (HIT) is a relatively rare condition burdened by a high rate of complications and mortality. Cardiac surgery is a high risk setting for this condition. But in...
      
2.
        
    
    Guidotti G, Liberati V, Sorrentino A, Lotti E, Crudele F, Rogolino A, et al.
  
  
    J Clin Med
    . 2024 Aug;
          13(15).
    
    PMID: 39124810
  
  
           Real-world data on the use of lipid-lowering therapy (LLT) in clinical practice show that about 80% of (very) high-cardiovascular (CV)-risk patients disregard the 2019 European Society of Cardiology (ESC) Guidelines'...
      
3.
        
    
    Bevilacqua S, Stefano P, Berteotti M, Del Pace S, Pieri M, Mandarano R, et al.
  
  
    Res Pract Thromb Haemost
    . 2024 Jul;
          8(4):102465.
    
    PMID: 39036670
  
  
          Background: Cardiac surgery is a high-risk setting for heparin-induced thrombocytopenia (HIT). However, large differences in its incidence, rate of thrombotic complications, and mortality have been reported in this context. Few...
      
4.
        
    
    Giusti B, Sticchi E, Capezzuoli T, Orsi R, Squillantini L, Giannini M, et al.
  
  
    Biomed Res Int
    . 2024 Jul;
          2024:2860547.
    
    PMID: 39035772
  
  
           In February 2021, a few cases of unusual, severe thrombotic events associated with thrombocytopenia reported after vaccination with ChAdOx1 nCoV-19 (Vaxzevria) or with Johnson & Johnson's Janssen vaccine raise concern...
      
5.
        
    
    Sodero A, Conti E, Piccardi B, Sarti C, Palumbo V, Kennedy J, et al.
  
  
    Transl Neurosci
    . 2024 Jul;
          15(1):20220344.
    
    PMID: 39005711
  
  
          Cerebral edema (CE) and hemorrhagic transformation (HT) are frequent and unpredictable events in patients with acute ischemic stroke (AIS), even when an effective vessel recanalization has been achieved. These complications,...
      
6.
        
    
    Marchi E, Muraca I, Berteotti M, Gori A, Valenti R, Marcucci R
  
  
    Int J Mol Sci
    . 2024 Jun;
          25(11).
    
    PMID: 38892037
  
  
          This review article focuses on the role of adenosine in coronary artery disease (CAD) diagnosis and treatment. Adenosine, an endogenous purine nucleoside, plays crucial roles in cardiovascular physiology and pathology....
      
7.
        
    
    Vignoli A, Gori A, Berteotti M, Cesari F, Giusti B, Bertelli A, et al.
  
  
    Life Sci
    . 2024 Jun;
          351:122796.
    
    PMID: 38852797
  
  
          Aims: Long-term oral anticoagulation is the primary therapy for preventing ischemic stroke in patients with atrial fibrillation (AF). Different types of oral anticoagulant drugs can have specific effects on the...
      
8.
        
    
    Rostagno C, Mannarino G, Cartei A, Rubbieri G, Ceccofiglio A, Gori A, et al.
  
  
    Clin Interv Aging
    . 2024 May;
          19:655-664.
    
    PMID: 38706637
  
  
          Purpose: Aim of the present study was to evaluate whether monitoring direct oral anticoagulant (DOAC) levels may improve management of anticoagulated patients who need surgery for hip fracture. Patients And...
      
9.
        
    
    Renda G, Bucciarelli V, Barbieri G, Lanuti P, Berteotti M, Malatesta G, et al.
  
  
    J Cardiovasc Dev Dis
    . 2024 Apr;
          11(4).
    
    PMID: 38667729
  
  
          Background: The impact of non-vitamin K antagonist oral anticoagulants (NOACs) on platelet function is still unclear. We conducted a comprehensive ex vivo study aimed at assessing the effect of the...
      
10.
        
    
    Barbieri G, Cassioli G, Kura A, Orsi R, Magi A, Berteotti M, et al.
  
  
    J Clin Lab Anal
    . 2024 Mar;
          38(5):e24998.
    
    PMID: 38444303
  
  
          Background: Lipoprotein(a) [Lp(a)] level variability, related to atherothrombotic risk increase, is mainly attributed to LPA gene, encoding apolipoprotein(a), with kringle IV type 2 (KIV2) copy number variation (CNV) acting as...